Dopamine D4 Receptor Neurons

Dopamine D4 Receptor Neurons

Overview

Dopamine D4 Receptor Neurons

Overview

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">Dopamine D4 Receptor Neurons</th>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:0000197](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>DRD4</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>11p15.5</td>
</tr>
<tr>
<td class="label">Protein</td>
<td>Dopamine D4 Receptor</td>
</tr>
<tr>
<td class="label">Family</td>
<td>D2-like (Gi/o-coupled)</td>
</tr>
<tr>
<td class="label">Length</td>
<td>387 amino acids</td>
</tr>
<tr>
<td class="label">Region</td>
<td>Density</td>
</tr>
<tr>
<td class="label">Prefrontal cortex</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hippocampus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Thalamus</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Basal ganglia</td>
<td>Variable</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Status</td>
</tr>
<tr>
<td class="label">ABT-724</td>
<td>Research</td>
</tr>
<tr>
<td class="label">ABT-670</td>
<td>Research</td>
</tr>
<tr>
<td class="label">PD-168,077</td>
<td>Research</td>
</tr>
<tr>
<td class="label">Compound</td>
<td>Clinical Use</td>
</tr>
<tr>
<td class="label">L-745,870</td>
<td>Research</td>
</tr>
<tr>
<td class="label">FAUC213</td>
<td>Research</td>
</tr>
<tr>
<td class="label">PNU-101,387G</td>
<td>Research</td>
</tr>
</table>

Dopamine D4 Receptor Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

<!-- multi-taxonomy-enrichment -->

Multi-Taxonomy Classification

Taxonomy Database Cross-References

External Database Links

• [Cell Ontology (CL:0000197)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_0000197)
• [OBO Foundry (CL:0000197)](http://purl.obolibrary.org/obo/CL_0000197)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Introduction

Dopamine D4 receptor neurons express the D4 subtype of dopamine receptors, a member of the D2-like family of G protein-coupled receptors. These neurons are prominently involved in cognitive functions including attention, working memory, and executive control. The D4 receptor has attracted particular interest due to its association with attention-deficit/hyperactivity disorder (ADHD), personality traits, and emerging links to neurodegenerative diseases. [@oak2000]

Molecular Biology

Receptor Structure

Gene Polymorphisms

The DRD4 gene contains a variable number tandem repeat (VNTR) polymorphism:

• 2-repeat: Common in some populations
• 4-repeat: Most common allele
• 7-repeat: Associated with novelty seeking
• Functional significance: Altered receptor trafficking and signaling

Signaling Mechanisms

Primary Signaling (Gi/o-coupled)

Secondary Pathways

• PI3K/Akt: Cell survival signaling
• Beta-arrestin recruitment: Receptor desensitization
• Dimerization: Functional consequences

Receptor Distribution

Brain Regions

Cell Type Expression

D4 receptors are expressed on:

• Pyramidal neurons: Excitatory projection neurons
• GABAergic interneurons: Local inhibition
• Astrocytes: Glial modulation
• Endothelial cells: Vascular regulation

Neurophysiology

Inhibitory Effects

• Membrane hyperpolarization: Through GIRK activation
• Reduced firing rate: Decreased neuronal excitability
• Decreased neurotransmitter release: Presynaptic inhibition
• Shunting inhibition: Increased membrane conductance

Modulatory Roles

• Attention: Filter irrelevant stimuli
• Working memory: Maintain information
• Cognitive flexibility: Set-shifting
• Reward processing: Motivation and learning

Function

Cognitive Operations

Attention

Working Memory

• Information maintenance: Active storage
• Manipulation: Cognitive operations
• Interference control: Protect representations
• Temporal integration: Bridge delays

Executive Function

• Planning: Sequence organization
• Inhibition: Suppress inappropriate responses
• Cognitive flexibility: Adapt to changes
• Decision making: Evaluate outcomes

Personality and Behavior

Novelty Seeking

• 7R allele: Associated with increased novelty seeking
• Dopaminergic tone: Modulated by D4
• Reward sensitivity: Enhanced responding
• Impulsivity: Associated traits

Disease Relevance

Alzheimer's Disease (AD)

D4 Receptor Changes

Mechanisms

• Amyloid-beta effects: Receptor trafficking
• Tau pathology: Downstream signaling
• Neuroinflammation: Altered receptor function

Therapeutic Implications

• D4 agonists: Potential cognitive enhancement
• PDE inhibitors: Increase cAMP signaling
• Novel compounds: D4-selective targets

Parkinson's Disease (PD)

Dopaminergic Therapy Effects

Cognitive Dysfunction

• Attention deficits: Common in PD
• Executive dysfunction: Frontal lobe features
• D4 role: Potential therapeutic target

Schizophrenia

D4 Receptor Hypothesis

Treatment

• Atypical antipsychotics: Often D4 antagonists
• Novel targets: Selective D4 modulators
• Adjunct strategies: Combined approaches

ADHD

DRD4 Polymorphism

Treatment

• Stimulants: Increase dopamine (non-selective)
• Non-stimulants: Atomoxetine (NET inhibitor)
• D4-selective: Under development

Substance Use Disorders

Reward Circuitry

Therapeutic Approaches

Pharmacological Modulation

D4 Agonists

D4 Antagonists

Clinical Considerations

• Blood-brain barrier: Required for CNS effects
• Selectivity: D2/D3 vs D4 specificity
• Dose-response: Therapeutic window considerations

Research Directions

Biomarker Development

• DRD4 genotyping: Risk stratification
• PET ligands: Receptor imaging
• Cognitive paradigms: D4 function measures

Drug Development

• D4 partial agonists: Balanced modulation
• Allosteric modulators: Novel mechanisms
• Combination therapy: Multi-target approaches

Gene Therapy

• Viral vectors: Targeted delivery
• CRISPR: Potential for correction
• Cellular therapy: Dopamine neuron replacement

Overview

Dopamine D4 Receptor Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Dopamine D4 Receptor Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

Cross-References

Related Cell Types

• Dopamine D2 Receptor Neurons
• Dopamine D3 Receptor Neurons
• Dopamine D5 Receptor Neurons
• Prefrontal Cortex Pyramidal Neurons

Related Mechanisms

• Dopamine Neurotransmission
• Prefrontal Cortical Function
• Working Memory Circuit

Related Diseases

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• Schizophrenia
• ADHD

See Also

• [Neurodegeneration — General mechanisms
• [Brain Regions — Anatomical context](/content/brain-regions)

• [Allen Brain Atlas](https://portal.brain-map.org/)

Pathway Diagram

The following diagram shows the key molecular relationships involving Dopamine D4 Receptor Neurons discovered through SciDEX knowledge graph analysis: